Last reviewed · How we verify
NCT05563610
Oral Penicillin Challenge and Allergy De-labeling in Children
Phase 4 trial testing Amoxicillin 500mg in Penicillin Allergy in 31 participants. Terminated before completion.
12 June 2024
Quick facts
| Lead sponsor | Phoenix Children's Hospital |
|---|---|
| Phase | Phase 4 |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 31 |
| Start date | 26 September 2022 |
| Primary completion | 12 June 2024 |
| Estimated completion | 12 June 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Amoxicillin 500mg — full drug profile →
Conditions studied
- Penicillin Allergy — all drugs for Penicillin Allergy →
Sponsor
Phoenix Children's Hospital
Who can join
Adults 2 to 17, any sex, with Penicillin Allergy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary purpose of this study is to investigate the portion of penicillin allergy labels that are not true allergies using oral amoxicillin challenges among pediatric patients. The secondary purpose is to evaluate the safety and feasibility of administering oral penicillin allergy challenges in the Pediatric Emergency Department.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05563610
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Amoxicillin 500mg
Trials testing the same drug.
- NCT06126731 — Combination Study of Antibiotics With Enzalutamide (PROMIZE) · Phase 1, PHASE2 · recruiting
- NCT05916716 — Use of a Novel Volume-stable Collagen Matrix (VCMX) in the Treatment of Single Gingival Recession Associated With Non-ca · NA · unknown
- NCT05916742 — Biofunctionalization of a Volume-stable Collagen Matrix (VCMX) for the Treatment of Single Gingival Recession · NA · unknown
- NCT04132479 — The Epidemiology and Optimal Treatment of Helicobacter Pylori in Myanmar · Phase 4 · completed
Other recruiting trials for Penicillin Allergy
Currently open trials in the same condition.
- NCT05464615 — Geisinger Antibiotic Allergy Pilot Program: Assess and Address · EARLY_PHASE1 · recruiting
- NCT07177690 — A Study of the Impact of Penicillin Allergy on Antimicrobial Resistance and ouTcomes · active not recruiting
Other Phoenix Children's Hospital trials
Trials by the same sponsor.
- NCT06372249 — A Clinical Trial of Soluble Fiber for Asthma · Phase 2 · recruiting
- NCT05925075 — Point of Care Lung Ultrasound in Preterm Infants with Respiratory Distress · enrolling by invitation
- NCT04344652 — Photoscreening for Retinoblastoma · NA · withdrawn
- NCT04040452 — Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery · Phase 4 · recruiting
- NCT03673618 — Soluble Corn Fiber Supplementation for Asthma · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05563610 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Phoenix Children's Hospital
- Last refreshed: 14 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05563610.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing